See also this year's filing and all EDGAR filings for this company.
PDF Report 0001302573_2019_OncoMed_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001302573')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001302573, OncoMed Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 63,727,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 623,000 |
| 3 | remainder_Assets | 728,000 |
| 4 | LiabilitiesCurrent | 12,644,000 |
| 5 | LiabilitiesNoncurrent | 100,000 |
| 6 | remainder_Liabilities | 4,103,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,172,000 |
| 9 | ResearchAndDevelopmentExpense | 34,443,000 |
| 10 | remainder_Expenses | 1,469,000 |
| 11 | remainder_Revenues | 45,983,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -318,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 65,078,000 |
| 1 | Liabilities | 16,847,000 |
| 2 | Expenses | 54,084,000 |
| 3 | Revenues | 45,983,000 |
| 4 | StockholdersEquity | 48,231,000 |
| 5 | NetIncome | -8,101,000 |
| 6 | ComprehensiveNetIncome | -8,260,000 |
| 7 | BaseVar | 91,155,000 |
| 8 | EconomicCapitalRatio | 1.82 |
Edgar->Model Mapping
Feature Distribution
Change over Time
